Ignite Creation Date:
2025-12-24 @ 12:50 PM
Ignite Modification Date:
2025-12-29 @ 6:19 PM
Study NCT ID:
NCT01437761
Status:
TERMINATED
Last Update Posted:
2017-04-12
First Post:
2011-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorbent Treatment Prescriptions Pilot Study
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D051437', 'term': 'Renal Insufficiency'}], 'ancestors': [{'id': 'D007674', 'term': 'Kidney Diseases'}, {'id': 'D014570', 'term': 'Urologic Diseases'}, {'id': 'D052776', 'term': 'Female Urogenital Diseases'}, {'id': 'D005261', 'term': 'Female Urogenital Diseases and Pregnancy Complications'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 12}, 'patientRegistry': False}, 'statusModule': {'whyStopped': 'Change of Institutional Affliation \\& Funding Changes', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2011-08'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-04', 'completionDateStruct': {'date': '2012-01', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-04-10', 'studyFirstSubmitDate': '2011-09-19', 'studyFirstSubmitQcDate': '2011-09-20', 'lastUpdatePostDateStruct': {'date': '2017-04-12', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2011-09-21', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2011-11', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Treatment Adequacy', 'timeFrame': '4 weeks', 'description': 'spKt/V, eKt/V, and Std Weekly Kt/V (Kt/V = dialysis adequacy)'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': False}, 'conditionsModule': {'conditions': ['Renal Failure']}, 'descriptionModule': {'briefSummary': 'This study will compare how well blood of renal failure patients is cleaned with the new 2008 Sorbent System using two different dialysate speeds.', 'detailedDescription': 'The "2008 Sorbent System" is a new type of hemodialysis machine that requires only about 2 gallons of dialysate for a treatment because it can turn used dialysate into fresh dialysate again by filtering it through a special cleaning cartridge (called a "sorbent"). This new machine is approved by the U.S. Food and Drug Administration to clean the blood of patients whose kidneys have failed.\n\nThis study will compare the degree of blood cleansing achieved with the new 2008 Sorbent System using two different speeds at which the dialysate runs through the dialysis machine. This will tell us if the faster speed really does provide better cleaning (and how much) with this new machine.\n\nHow well the blood of a patient is cleaned by this procedure is determined by several factors. For example, longer treatment times generally provide better blood cleansing. Higher speeds at which the cleaning fluid runs through the artificial kidney do, too.\n\nSince the 2008 Sorbent System is a new machine (and in some ways different from standard hemodialysis machines), other aspects may be different, too, between the 2008 Sorbent System and regular hemodialysis machines. Specifically, this study looks at how well this new machine corrects the patients\' acid-base status (a common requirement in these patients), what effect the treatment has on inflammation in the patients\' blood, how the levels of important substances in the blood are influenced (acetate, sulfate, nitrate, carbon dioxide), and if cleaning fluid in the 2008 Sorbent System contains any substances that are not found in the cleaning fluid used by regular hemodialysis machines.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '88 Years', 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'End-stage renal disease patients', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* age \\</=18 years\n* end-stage renal disease (ESRD) patient on chronic high-flux hemodialysis for \\</= 6 months at time of enrollment\n* well-functioning fistula, graft or catheter as hemodialysis access, achieving blood flow rates of \\>/= 300 mL/min\n* ability to understand the English language\n\nExclusion Criteria:\n\n* Pre-dialysis serum blood urea nitrogen (BUN) concentration below 30 mg/dL in the last three months\n* Severe Coronary Heart Disease or Heart Failure (New York Heart Association class IV)\n* Active Infections\n* Hepatitis B\n* Any other active infection that has required antibiotic treatment in the preceding eight weeks\n* Pre-study lab values of any of the following (in the most recent routine lab work)\n* Sodium - Na+ \\> 150 mmol/L, Na+ \\< 132 mmol/L\n* Potassium - K+ \\> 6.5 mmol/L, K+ \\< 3.5 mmol/L\n* Total Calcium - Ca \\> 12 mg/dL (3 mmol/L), total Ca \\< 7.2 mg/dL (1.8 mmol/L)'}, 'identificationModule': {'nctId': 'NCT01437761', 'acronym': 'Sorb2', 'briefTitle': 'Sorbent Treatment Prescriptions Pilot Study', 'organization': {'class': 'OTHER', 'fullName': 'Renal Research Institute'}, 'officialTitle': 'Hemodialysis With the 2008 Sorbent System: A Pilot Evaluation of Different Treatment Prescriptions', 'orgStudyIdInfo': {'id': '150-11'}}, 'armsInterventionsModule': {'armGroups': [{'label': '2008 Sorbent system', 'description': 'Hemodialysis with the 2008 Sorbent system', 'interventionNames': ['Device: 2008 Sorbent System']}], 'interventions': [{'name': '2008 Sorbent System', 'type': 'DEVICE', 'description': '2008 Sorbent System with dialysate flow rates (Qd) of 400 and 500 ml/min while maintaining a constant blood flow rate (Qb) and constant dialyzer (KoA).', 'armGroupLabels': ['2008 Sorbent system']}]}, 'contactsLocationsModule': {'locations': [{'zip': '10128', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Yorkville Dialysis Center', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}], 'overallOfficials': [{'name': 'Peter Kotanko, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Renal Research Institute'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Renal Research Institute', 'class': 'OTHER'}, 'collaborators': [{'name': 'Renal Solutions, Inc.', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}}